133 results
Page 2 of 7
8-K
EX-99.1
jbxs8ajmx 1wi798wwx
15 May 20
Top-line Results from a Phase 2b Study of PTI-125 in Alzheimer’s Disease Does Not Meet Primary Endpoint
8:20am
8-K
EX-99.1
3wbtupf4hn m8l
6 May 20
Cassava Sciences Reports First Quarter 2020 Financial Results and Provides Business Update
8:16am
8-K
EX-99.1
jvyl8ncjj5vole8ro
26 Mar 20
Cassava Sciences Announces Full-year 2019 Financial Results and Anticipated Key Milestones for 2020
8:17am
8-K
EX-99.2
hmkvgphad clb9
6 Dec 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
nqfdmuq ewz
29 Oct 19
Cassava Sciences Announces Recent Clinical Highlights and Third Quarter 2019 Financial Results
8:29am
8-K
EX-99.1
rc9ex063 lvktgw
9 Sep 19
Cassava Sciences Reports Positive Phase 2a Clinical Results in Alzheimer’s Patients
7:45am
8-K
EX-99.1
vc0nz33 5a5lvk
8 Feb 19
Pain Therapeutics Announces Feedback from
4:04pm
8-K
EX-99.1
bwcuz
6 Aug 18
Other Events
7:00am